Slavko Kralj

Meet Slavko Kralj, a brilliant inventor from Oegstgeest, Netherlands, who has made quite a mark in the field of biochemistry and enzymology. With an impressive portfolio of 15 patents, Kralj's innovative work has contributed significantly to the synthesis and functionality of glucan.

His latest patents revolve around the synthesis of glucan with specific glycosidic linkages, and the use of phosphorylase enzymes in these reactions. The first patent focuses on the synthesis of glucan comprising alpha-1,3 glycosidic linkages. Kralj's method involves utilizing beta-glucose-1-phosphate (beta-G1P), an acceptor molecule, and an alpha-1,3-glucan phosphorylase enzyme to produce oligosaccharides and polysaccharides with alpha-1,3 glycosidic linkages.

Another patent explores the synthesis of glucan containing beta-1,3 glycosidic linkages. By using alpha-glucose-1-phosphate (alpha-G1P), an acceptor molecule, and a beta-1,3-glucan phosphorylase enzyme, Kralj has developed a method to create oligosaccharides and polysaccharides with beta-1,3 glycosidic linkages. Additionally, this patent also details methods for isolating beta-1,3-glucan.

Throughout his career, Slavko Kralj has collaborated with several noteworthy companies, including Danisco US Inc and DuPont Nutrition Biosciences APS. These organizations have provided the platform for Kralj to further his research and turn his innovative ideas into practical applications.

Among his colleagues, Richard Ray Bott and Thijs Kaper stand out as important collaborators. Their collective expertise and dedication have undoubtedly contributed to the success of Kralj's groundbreaking inventions.

Slavko Kralj's patents in glucan synthesis, along with his association with esteemed companies and talented coworkers, demonstrate his commitment to advancing the field of biochemistry. His innovative contributions will undoubtedly pave the way for further advancements in this area, benefiting industries and scientific communities alike.